According to Biolase 's latest financial reports the company's total assets are โน2.31 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | โน3.15 B | -23.21% |
2021-12-31 | โน4.11 B | 37.15% |
2020-12-31 | โน3.00 B | 32.11% |
2019-12-31 | โน2.27 B | -15.67% |
2018-12-31 | โน2.69 B | -1.87% |
2017-12-31 | โน2.74 B | -3.7% |
2016-12-31 | โน2.85 B | 1.51% |
2015-12-31 | โน2.80 B | -25.42% |
2014-12-31 | โน3.76 B | 96.34% |
2013-12-31 | โน1.91 B | 9.53% |
2012-12-31 | โน1.75 B | 11.02% |
2011-12-31 | โน1.57 B | 93.91% |
2010-12-31 | โน0.81 B | -20.98% |
2009-12-31 | โน1.02 B | -40.04% |
2008-12-31 | โน1.71 B | -1.3% |
2007-12-31 | โน1.73 B | -19.18% |
2006-12-31 | โน2.15 B | 5.94% |
2005-12-31 | โน2.03 B | -20.18% |
2004-12-31 | โน2.54 B | 25.19% |
2003-12-31 | โน2.03 B | 164.82% |
2002-12-31 | โน0.76 B | 110.35% |
2001-12-31 | โน0.36 B |